ISSN: 1068-9265

Journal Guideline

Annals of Surgical Oncology Q1 Unclaimed

Springer New York United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Annals of Surgical Oncology is one of the leading journals in Oncology and Surgery. Annals is a monthly publication that features original articles on the latest advances in oncology for surgeons from all specialties.Annals is currently included in the following indexing services in print and/or electronic format: Index Medicus, Current Contents/Clinical Medicine, Excerpta Medica, Science Citation Index and Science Citation Index Expanded.Annals benefits surgeons, oncologists, hematologists, radiologists, general practitioners, pathologists, researchers, academicians, and other clinical professionals interested in all aspects of the surgical treatment of cancer.Annals of Surgical Oncology is the official journal of the Society of Surgical Oncology. Why publish with us We are the official journal of the Society of Surgical Oncology, and a member benefit for the American Society of Breast Surgeons. The Leading Resource in Surgical Oncology, promoting both clinical and translational cancer research, with an emphasis on clinical trials. New features include The Landmark Series highlighting seminal clinical trials, which represent essential resources for trainee and practicing Surgical Oncologists. We provide high levels of author satisfaction, with 99% of our published authors reporting that they would definitely or probably publish with us again. It has an SJR impact factor of 1,037.

Annals of Surgical Oncology focuses its scope in these topics and keywords: cancer, patients, breast, gastric, lymph, carcinoma, mastectomy, surgical, node, tomography, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Surgery (Q1) Oncology (Q2)

Price

3190 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

1,037

SJR Impact factor

202

H Index

1796

Total Docs (Last Year)

3964

Total Docs (3 years)

27001

Total Refs

7973

Total Cites (3 years)

2827

Citable Docs (3 years)

1.97

Cites/Doc (2 years)

15.03

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Molecular Cancer Q1
Journal of Thoracic Oncology Q1
JAMA oncology Q1
Cancer Discovery Q1
Journal of Hematology and Oncology Q1

Compare this journals

Aims and Scope

Best articles by citations

Melanoma-Inhibiting Activity Assay Predicts Survival in Patients Receiving a Therapeutic Cancer Vaccine After Complete Resection of American Joint Committee on Cancer Stage III Melanoma

Omitting Completion Dissection in Melanoma? Help is Available for Surgeons Coping Without Routine Dissection, But More Work is Needed

Application of Molecular Diagnosis for Detection of Peritoneal Micrometastasis and Evaluation of Preoperative Chemotherapy in Advanced Gastric Carcinoma

Functional Outcome after Treatment of Lower Extremity Soft Tissue Sarcoma: What Should We Tell Our Patients?

Correlation Between MUC5AC Expression and the Prognosis of Patients With Adenocarcinoma of the Uterine Cervix

Paradigm of Metastasis for Melanoma and Breast Cancer Based on the Sentinel Lymph Node Experience

Current Status and Future Prospects of Sentinel Node Navigational Surgery for Gastrointestinal Cancers

Refined Staging by Sentinel Lymph Node Biopsy to Individualize Therapy in Anal Cancer

Early Oral Versus "Traditional" Postoperative Feeding in Gynecologic Oncology Patients Undergoing Intestinal Resection: a Randomized Controlled Trial

Deleted in Oral Cancer-1 Expression Upregulates Proapoptosis Elements in Microsatellite-Unstable Human Colorectal Cancer

Atypical Lipomatous Tumor/Well-Differentiated Liposarcoma of the Extremity and Trunk Wall: Importance of Histological Subtype With Treatment Recommendations

Indocyanine Green-Enhanced Fluorescence in Laparoscopic Duodenum-Preserving Pancreatic Head Resection: Technique with Video

SHOW MORE ARTICLES

Minimal Residual Disease Assessment in Sentinel Nodes of Breast and Gastrointestinal Cancer: A Plea for Standardization

Lymphatic Drainage of the Skin

Failure to Remove True Sentinel Nodes Can Cause Failure of the Sentinel Node Biopsy Technique: Evidence from Antimony Concentrations in False-Negative Sentinel Nodes from Melanoma Patients

Editorial: Locoregional Control of Breast Cancer: Surgical Technique Does Matter

Lymphatic Mapping in the Molecular Era

Evaluation of the Relationship Between Flap Tension and Tissue Perfusion in Implant-Based Breast Reconstruction Using Laser-Assisted Indocyanine Green Angiography

Residual Mesorectal Lymph Node Involvement Following Neoadjuvant Combined-Modality Therapy: Rationale for Radical Resection?

Identification of Molecular Markers Specific for Pancreatic Neuroendocrine Tumors by Genetic Profiling of Core Biopsies

Universal Applications of Sentinel Node Technology

Touch Preparation or Frozen Section for Intraoperative Detection of Sentinel Lymph Node Metastases From Breast Cancer

Clinicopathological Utility of Molecular Staging for Melanoma Patients Undergoing Sentinel Lymphadenectomy

Clinicopathology and Genetic Profile of Synchronous Multiple Small Adenocarcinomas: Implication for Surgical Treatment of an Uncommon Lung Malignancy